Original article: cardiovascular
Pretreatment with angiotensin-converting enzyme inhibitors attenuates ischemia-reperfusion injury

https://doi.org/10.1016/S0003-4975(02)03461-6Get rights and content

Abstract

Background. The Heart Outcomes Prevention Evaluation (HOPE) trial demonstrated that ischemic events are decreased in patients receiving angiotensin-converting enzyme (ACE) inhibitors. This study sought to determine whether pretreatment with ACE inhibitors would attentuate ischemic injury during surgical revascularization of ischemic myocardium.

Methods. In a porcine model, the second and third diagonal vessels were occluded for 90 minutes, followed by 45 minutes of cardioplegic arrest, and 180 minutes of reperfusion. Ten pigs received quinapril (20 mg PO q.d.) for 7 days prior to surgery; 10 others received no-ACE inhibitors.

Results. Quinapril-treated animals required less cardioversions for ventricular arrhythmias (1.58 ± 0.40 vs 2.77 ± 0.22; p < 0.05), had higher wall motion scores assessed by two-dimensional echocardiography (4 = normal to −1 = dyskinesia; 2.11 ± 0.10 vs 1.50 ± 0.07; p < 0.05), more complete coronary artery endothelial relaxation to bradykinin (45% ± 3% vs 7% ± 4%; p < 0.005), and lower infarct size (24.0% ± 3.0% vs 40.0% ± 1.7%; p < 0.0001).

Conclusions. ACE inhibition prior to coronary revascularization enhances myocardial protection by decreasing ventricular irritability, improving regional wall motion, lowering infarct size, and preserving endothelial function.

Section snippets

Randomization

Twenty pigs were entered into the study and none were excluded. Animals were fed a standard chow diet to which either quinapril (20 mg PO q.d.) or a placebo were added for 1 week. They were randomized by selecting a sealed envelope, which contained a 7-day supply of medication, such that the investigators were blinded to the identity of the medication.

Preparation

Adult pigs (35 to 38 kg) were premedicated with ketamine (15 mg/kg intramuscularly [IM]) and xylazine (0.5 mg/kg IM), anesthetized with

Hemodynamic parameters during coronary occlusion prior to CPB

Table 1 summarizes the changes in hemodynamics during the 90 minutes of coronary occlusion prior to CPB. There was no significant difference in heart rate, MAP, or LVEDP between quinapril and non-ACE inhibitor animals prior to coronary occlusion. Following 90 minutes of coronary occlusion, both groups showed small, but significant (p < 0.05) decreases in heart rate and MAP from preischemic values, although there was no difference between the quinapril and no-ACE inhibitor groups. LVEDP was

Comment

Previous studies have shown that ACE inhibitors may play an important role in minimizing ischemic events during and following CABG surgery 5, 6, 7. The results of this study indicate that they may also play an important role in preventing myocardial injury when given prior to surgery.

The beneficial effects of ACE inhibitors following CABG were reported in two clinical trials involving high tissue affinity ACE inhibitors 5, 6. In the QUOVADIS (Quinapril on Vascular ACE and Determinants of

Acknowledgements

This work was supported in part by a grant from Pfizer Pharmaceuticals Inc, New York, NY.

References (21)

There are more references available in the full text version of this article.

Cited by (0)

View full text